Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.24 -0.14 (-0.65%)
As of: Nov 16, 2026 · 9:54 AM EST

Amneal Pharmaceuticals (AMRX) Divestments (2024)

Updated

Amneal Pharmaceuticals (AMRX) reported Divestments of $7.01 million for Q4 2024.

Analysis

Amneal Pharmaceuticals (AMRX) Divestments (2024) Analysis & Trends

For FY2024, Amneal Pharmaceuticals posted Divestments of $11.99 million.

  • Divestments has a five-year compound annual growth rate of -19.2% (FY2019 to FY2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Eli Lilly 1,304.70 Bn 1,278.32 Bn 20.46 Bn -
2 Johnson & Johnson 690.68 Bn 610.54 Bn 17.30 Bn -
3 AbbVie 528.28 Bn 496.29 Bn 13.12 Bn -
4 Merck 365.24 Bn 328.18 Bn 13.19 Bn -
5 Novartis Ag 314.66 Bn 287.90 Bn - 42.00 Mn
6 Astrazeneca 288.53 Bn 262.05 Bn 13.26 Bn -
7 Amgen 253.39 Bn 205.04 Bn 7.58 Bn -
8 Gilead Sciences 210.48 Bn 185.59 Bn 6.73 Bn -
9 Pfizer 165.27 Bn 112.63 Bn 12.56 Bn -
10 Amneal Pharmaceuticals 7.17 Bn 6.41 Bn 334.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 7.01 Mn
API Access

Amneal Pharmaceuticals Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=divestments&ticker=AMRX&period=max&api_key=YOUR_API_KEY